Literature DB >> 17535059

Isoniazid overdose : a case series, literature review and survey of antidote availability.

Graeme Maw1, Peter Aitken.   

Abstract

Tuberculosis has re-emerged as a significant public health threat over the last decade both globally and within Australia. This is thought to be largely due to the HIV epidemic, a growing itinerant population, and immigration. The antibiotic isoniazid remains an integral part of drug therapy. With the numbers of patients receiving isoniazid remaining high, the number of cases of acute poisoning is expected to be significant. This paper presents a series of two cases of isoniazid poisoning presenting to a tertiary referral centre in North Queensland. Isoniazid toxicity produces a triad of coma, metabolic acidosis and seizures. The seizures are often refractory to traditional antiepileptics. A specific antidote is available (pyridoxine [vitamin B6]) and both patients were administered this as part of their treatment. We also surveyed all hospitals in Australia with an accredited adult Emergency Department to assess the availability of pyridoxine.

Entities:  

Year:  2003        PMID: 17535059     DOI: 10.2165/00044011-200323070-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  19 in total

1.  A 23-year-old with refractory seizures following an isoniazid overdose.

Authors:  Rebecca A Steinmann; Marianne K Rickel
Journal:  J Emerg Nurs       Date:  2002-02       Impact factor: 1.836

2.  Seizures in a 13-year-old girl.

Authors:  Jane F Knapp; Tiffany Johnson; Sarah Alander
Journal:  Pediatr Emerg Care       Date:  2003-02       Impact factor: 1.454

3.  Acute isoniazid neurotoxicity during preventive therapy.

Authors:  I Martinjak-Dvorsek; V Gorjup; M Horvat; M Noc
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

4.  Isoniazid overdose. Successful treatment with pyridoxine and hemodialysis.

Authors:  J M Cash; E T Zawada
Journal:  West J Med       Date:  1991-12

5.  Treatment of acute isoniazid toxicity.

Authors:  M L Sievers; R N Herrier
Journal:  Am J Hosp Pharm       Date:  1975-02

6.  Isoniazid: a review with emphasis on adverse effects.

Authors:  A L Goldman; S S Braman
Journal:  Chest       Date:  1972-07       Impact factor: 9.410

7.  Intravenous pyridoxine-induced metabolic acidosis.

Authors:  F Lovecchio; S C Curry; K A Graeme; K L Wallace; J Suchard
Journal:  Ann Emerg Med       Date:  2001-07       Impact factor: 5.721

8.  Single high-dose pyridoxine treatment for isoniazid overdose.

Authors:  S Wason; P G Lacouture; F H Lovejoy
Journal:  JAMA       Date:  1981-09-04       Impact factor: 56.272

9.  Tuberculosis notifications in Australia, 2001.

Authors:  Megge Miller; Ming Lin; Jenean Spencer; Ral Antic; Ivan Bastian; Amanda Christensen; Mark Hurwitz; Anastasios Konstantinos; Vicki Krause; Avner Misrachi; Graham Tallis; Justin Waring; Moira McKinnon
Journal:  Commun Dis Intell Q Rep       Date:  2002

10.  Acute isoniazid poisoning in childhood.

Authors:  J Miller; A Robinson; A K Percy
Journal:  Am J Dis Child       Date:  1980-03
View more
  4 in total

Review 1.  Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes.

Authors:  D Nicholas Bateman; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2015-10-24       Impact factor: 4.335

2.  Antibiotic-induced neurotoxicity.

Authors:  Shamik Bhattacharyya; Ryan Darby; Aaron L Berkowitz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

3.  Case Files of the University of California, San Francisco Medical Toxicology Fellowship: Seizures and a Persistent Anion Gap Metabolic Acidosis.

Authors:  Ann Arens; Craig Smollin
Journal:  J Med Toxicol       Date:  2016-04-14

4.  A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver.

Authors:  Feng Li; Pengcheng Wang; Ke Liu; Mariana G Tarrago; Jie Lu; Eduardo N Chini; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2016-08-16       Impact factor: 3.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.